Tradegate
06.08.26 | 15:37
5,800 Euro
+0,87 % +0,050
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,750 | 6,000 | 16:24 | |
| 5,800 | 5,950 | 16:24 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15:34 | Exagen auf Wachstumskonferenz von Canaccord Genuity: Turnaround gewinnt an Fahrt | 4 | Investing.com Deutsch | ||
| 04.08. | Exagen targets $72M-$75M 2026 revenue outlook as profitability nears breakeven | 3 | Seeking Alpha | ||
| EXAGEN Aktie jetzt für 0€ handeln | |||||
| 04.08. | Exagen Q2 2026 slides: record revenue, stock surges 30% on results | 1 | Investing.com | ||
| 04.08. | Exagen Q2 2026 slides: record revenue, stock surges 36% | 2 | Investing.com | ||
| 04.08. | EXAGEN INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 04.08. | Exagen GAAP EPS of -$0.13 beats by $0.06, revenue of $19.94M beats by $2.07M | 2 | Seeking Alpha | ||
| 04.08. | Exagen Inc. Reports Second Quarter 2026 Financial Results | 415 | GlobeNewswire (Europe) | Achieved record total revenue, test volume and trailing twelve-month ASP Reduced net loss by nearly 30% and narrowed adjusted EBITDA loss to $0.1 million Increased full-year revenue guidance to... ► Artikel lesen | |
| 04.08. | EXAGEN INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 21.07. | Exagen Inc.: Exagen to Announce Second Quarter Financial Results on August 4, 2026 | 1 | GlobeNewswire (USA) | ||
| 09.06. | EXAGEN INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.06. | Exagen Inc.: Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus | 1 | GlobeNewswire (USA) | ||
| 12.05. | BTIG senkt Kursziel für Exagen auf 8 US-Dollar, bestätigt aber 'Buy'-Rating | 6 | Investing.com Deutsch | ||
| 12.05. | Exagen stock price target lowered to $8 by BTIG on valuation | 1 | Investing.com | ||
| 12.05. | Exagen reaffirms $70M-$73M 2026 revenue guidance as it targets $600-$650 ASP over time | 1 | Seeking Alpha | ||
| 11.05. | Exagen Inc. (XGN) Reports Q1 Loss, Beats Revenue Estimates | 1 | Zacks | ||
| 11.05. | Exagen: EPS übertrifft Schätzungen um 0,05 $ - Umsatz besser als erwartet | 1 | Investing.com Deutsch | ||
| 11.05. | EXAGEN INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 11.05. | Exagen beats top-line and bottom-line estimates; reaffirms FY26 outlook | 1 | Seeking Alpha | ||
| 11.05. | Exagen Inc. Reports First Quarter 2026 Results | 266 | GlobeNewswire (Europe) | CARLSBAD, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2026... ► Artikel lesen | |
| 11.05. | EXAGEN INC. - 8-K, Current Report | - | SEC Filings |
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HENRY SCHEIN | 76,00 | -0,65 % | Henry Schein Inc. Profit Advances In Q2 | MELVILLE (dpa-AFX) - Henry Schein Inc. (HSIC) announced earnings for its second quarter that Increases, from last yearThe company's bottom line totaled $94 million, or $0.82 per share. This... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,520 | +1,33 % | Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test | Submission includes a concurrent CLIA Waiver by Application for use of the test on the Co-Dx PCR Pro® instrument in decentralized point-of-care settings
SALT LAKE... ► Artikel lesen | |
| AMBU | 9,830 | +0,87 % | Ambu Q1 2025/26 slides: endoscopy growth offsets FX headwinds | ||
| CYTOSORBENTS | 0,298 | -6,29 % | Cytosorbents Corp: CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | Highlighting Four Independent Drivers of Shareholder Value
PRINCETON, N.J., Aug. 6, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,900 | -1,52 % | Clover Health auf der Canaccord Genuity Konferenz: Wachstum trifft auf Profitabilität | ||
| FULGENT GENETICS | 16,300 | -1,81 % | Fulgent expects $330M-$340M 2026 revenue as billing transition lowers collection rates | ||
| PERIMETER MEDICAL IMAGING AI | 0,188 | +3,30 % | Perimeter Medical Imaging AI Inc.: Perimeter Announces First Quarter 2026 Financial Results | Conference call/webcast today at 5:00 pm ET
TORONTO and DALLAS, May 28, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter"... ► Artikel lesen | |
| ICON | 139,90 | -2,44 % | ICON plc: ICON Announces Pricing of USD 2.15 Billion Notes | ICON plc (NASDAQ: ICLR) ("ICON"), a world-leading clinical research organization, today announced the pricing by its wholly-owned subsidiary, ICON Investments Six Designated Activity Company (the... ► Artikel lesen | |
| IMAGIN MEDICAL | - | - | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.05.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 15.05.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.05.2026.ISIN NameCA2985962067 EUREKA... ► Artikel lesen | |
| MEMPHASYS | 0,002 | -20,00 % | MEMPHASYS LIMITED: Pivotal Felix Study Receives First Scientific Presentation | ||
| ESTABLISHMENT LABS | 74,50 | +14,37 % | ESTABLISHMENT LABS HOLDINGS INC. - 10-Q, Quarterly Report | ||
| EMBECTA | 4,300 | -0,85 % | Embecta adds to earnings rally with another 9% advance | ||
| CHECK-CAP | 1,090 | -7,63 % | MBody AI Corp: Check-Cap Announces Reverse Share Split | ISFIYA, Israel, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. ("Check-Cap" or the "Company") (NASDAQ: MBAI) today announced a 1-for-7 reverse share split (the "Reverse Share Split") of the Company's... ► Artikel lesen | |
| ELECTROCORE | 7,250 | +5,84 % | ElectroCore targets positive adjusted EBITDA in Q3 2027 while lifting 2026 revenue growth outlook to greater than 30% | ||
| CATHETER PRECISION | 0,279 | -6,87 % | Catheter Precision, Inc.: Flyte Achieves Record Revenues in July | July 2026 Revenue Increased 102% sequential July Over June to Approximately $640,000 Retail Platform, Strategic Partnerships and Influencer Marketing Fuel Accelerating Growth FORT MILL, S.C., Aug.... ► Artikel lesen |
EXAGEN INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 5,800 Euro und damit +0,87 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXAGEN INC finden Sie auf Wallstreet Online.